The content on this site is intended for healthcare professionals only
Dr Matthew Maddocks discusses the dangers of insufficient exercise in patients with advanced cancer. Various exercise programmes are being offered to patients both alongside and after chemotherapy. Dr Maddocks outlines the difficulties faced motivating some patients, the way that this can be addressed and considers the potential for the programme to be offered on a national scale as part of a standard multidiscipline approach to cancer care.
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy-induced nausea and vomiting in NSCLC patients
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Latest in EGFR mutated NSCLC
ASCO 2024: Lung cancer highlights
Isatuximab in combination with pomalidomide and dexamethasone shows promising efficacy in 2nd line RRMM
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC
Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours
